COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest (COOL)
Clinical and Neurological Outcome With Two Different Cooling Methods (Invasive and Non-invasive) After Sudden Cardiac Arrest
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Leipzig, Germany, 04289
- University of Leipzig, Heart Center, Cardiology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ROSC after SCA due to VF/VT or PEA/Asystolia
- GCS 3
Exclusion Criteria:
- Non-cardiac SCA
- Pregnancy
- Unstable Circulation instead of High-dose Inotropics
- Life-expectancy reducing concomitant illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: CG
Coolgard: invasive Cooling
|
invasive Cooling via femoral ICY-catheter
|
|
Active Comparator: AS
ArcticSun: Surface-Cooling
|
Noninvasive surface-cooling by saline-cooled thermo-vest
|
|
Sham Comparator: UnCOOL
No Cooling-Therapy due to non-operational cooling-devices
|
Intensive care-treatment without cooling
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time to reach the target temperature
Time Frame: Twenty-four hours
|
Twenty-four hours
|
|
NSE as a parameter for cerebral damage
Time Frame: Seventy-two hours
|
Seventy-two hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Neurologic outcome
Time Frame: Six months
|
Six months
|
|
Survival
Time Frame: Six months
|
Six months
|
|
Periprocedural complications
Time Frame: Seventy-two hours
|
Seventy-two hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Holger Thiele, Associate Professor, study chair
- Study Director: Undine Pittl, MD, Study Sub-Investigator
Publications and helpful links
General Publications
- Zeiner A, Holzer M, Sterz F, Behringer W, Schorkhuber W, Mullner M, Frass M, Siostrzonek P, Ratheiser K, Kaff A, Laggner AN. Mild resuscitative hypothermia to improve neurological outcome after cardiac arrest. A clinical feasibility trial. Hypothermia After Cardiac Arrest (HACA) Study Group. Stroke. 2000 Jan;31(1):86-94. doi: 10.1161/01.str.31.1.86.
- Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002 Feb 21;346(8):557-63. doi: 10.1056/NEJMoa003289.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- COOL-Trial
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.